San Antonio – Mar. 1st, 2023 – The development of next-generation sequencing (NGS) technology, a wide array of informatics, and robotics are some of the most recent technological advancements in life science instrumentation and research tools. According to a recent study by Frost & Sullivan on the global market for life science instruments and research tools, investments in lab automation and analytics will hasten the growth of the lab instrumentation market. The global market is anticipated to grow at a compound annual growth rate (CAGR) of 6.4%, from $66.37 billion in 2021 to $90.41 billion in 2026.
For further information on this analysis, please click here.
“With the growing focus on decentralized diagnostics in both developed and developing economies, demand for portable instruments is expected to increase,” said Lucila Martin, Healthcare Research Analyst at Frost & Sullivan. “Additionally, higher demand for smaller instruments has increased pressure on original equipment manufacturers (OEMs) to develop and supply parts to support the development of portable instruments.”
Martin added: “Democratization of NGS drove the growth of the global genomic sector, enabling genomics and proteomics to become promising business segments to propel the market. From a technological perspective, expanding analytical chemicals with laboratory automation and informatic instruments offers a lucrative growth prospect.”
To tap into the growth opportunities of the instrumentation and research tool industry, market participants should:
- Invest in developing countries to build their capacity and capability, focusing on sales and after-sales support systems.
- Focus on artificial intelligence (AI) in lab optimization and predictive analytics for instrument lifecycle analytics as they present lucrative growth prospects for big data analytics companies.
- Develop highly customized chips and parts to support the development of portable equipment
Global Life Science Instrumentation and Research Tool Growth Opportunities is the latest addition to Frost & Sullivan’s Healthcare research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.
About Frost & Sullivan
For over six decades, Frost & Sullivan has helped build sustainable growth strategies for Fortune 1000 companies, governments, and investors. We apply actionable insights to navigate economic changes, identify disruptive technologies, and formulate new business models to create a stream of innovative growth opportunities that drive future success. Contact us: Start the discussion
Global Life Science Instrumentation and Research Tool Growth Opportunities
PDE9
Contact:
María Alejandra Briceño
Corporate Communications
E: [email protected]
https://staging.frost.com/
